Several prescription medications will cause a positive result on a barbiturate drug test, and a few common over-the-counter painkillers can trigger a false positive. Barbiturate screens are designed to detect a class of sedative drugs, but the way these tests work means they sometimes flag substances that aren’t barbiturates at all. Here’s what actually shows up and why.
Barbiturate Medications That Cause a True Positive
The FDA-approved barbiturates still in clinical use are phenobarbital, butalbital, pentobarbital, primidone, amobarbital, and methohexital. If you take any of these, you will test positive for barbiturates. Secobarbital is also detectable, and in fact most standard urine screens are specifically calibrated to look for secobarbital’s chemical structure as a stand-in for the entire barbiturate class.
The most common scenario is butalbital, which is an ingredient in several widely prescribed headache medications for tension and migraine headaches. Many people don’t realize the combination pill they take for headaches contains a barbiturate. Phenobarbital is another frequent cause, prescribed for epilepsy and seizure disorders. Both are reliably picked up by standard immunoassay screening with good sensitivity.
Primidone Converts to Phenobarbital in Your Body
Primidone is an anti-seizure medication that your body metabolizes into phenobarbital. This isn’t a testing error or cross-reactivity. Your liver literally converts primidone into a barbiturate as part of normal drug metabolism. According to Mayo Clinic Labs, the phenobarbital produced from primidone can accumulate to levels significant enough that toxicity from primidone is primarily attributed to this metabolite. If you take primidone, you should expect a positive barbiturate result on any standard drug screen.
Medications That Cause False Positives
A false positive means the test flags barbiturates even though you haven’t taken one. This happens because the initial screening test (an immunoassay) works by recognizing molecular shapes, and some non-barbiturate drugs have structures similar enough to fool it.
The two best-documented culprits are ibuprofen and naproxen, both available over the counter. Research published in clinical toxicology literature confirmed false-positive barbiturate results in patients taking each of these common painkillers. That said, it doesn’t happen often. A prospective study examining this issue found the overall likelihood of a false positive from ibuprofen or naproxen was small, meaning most people taking these drugs will test negative. But it does occur, and if you’re facing a drug test and take either one regularly, it’s worth knowing.
Phenytoin, an anti-seizure medication, has also been documented to cause false-positive barbiturate results. Phenytoin and one of its breakdown products share enough structural similarity with barbiturates to trip the immunoassay. This was identified in clinical case reports and is a recognized interference in toxicology testing.
How Long Barbiturates Stay Detectable
Detection windows vary dramatically depending on which barbiturate is involved. Most barbiturates are fast-acting, and their presence in urine indicates use within the past three days. Pentobarbital and secobarbital fall into this category.
Phenobarbital is the major exception. It has a very long half-life, which means it clears your system slowly. A urine test can detect phenobarbital for up to 30 days after your last dose. This matters for anyone taking phenobarbital directly or taking primidone (which converts to phenobarbital). Even after stopping the medication, you could continue testing positive for weeks.
What Happens After a Positive Screen
Standard drug testing uses a two-step process. The first step is an immunoassay, which is fast and inexpensive but prone to the cross-reactivity issues described above. For barbiturates, the screening threshold is typically set at 300 ng/mL, a cutoff recommended by the scientific community for workplace and clinical testing.
If the initial screen comes back positive, the sample goes through confirmatory testing using gas chromatography-mass spectrometry (GC-MS). This second test identifies the exact molecules present in your sample rather than just recognizing general shapes. GC-MS can distinguish phenobarbital from ibuprofen, butalbital from phenytoin, and so on. A false positive on the initial screen will not survive confirmatory testing.
This is why a single positive immunoassay result isn’t treated as definitive. If you test positive and believe it’s a false positive from ibuprofen, naproxen, or phenytoin, requesting confirmatory testing will resolve the question. Workplaces and testing programs that follow federal guidelines are required to confirm positive screens before reporting results.
Quick Reference: Drugs That Trigger a Positive
- Phenobarbital: True positive, detectable up to 30 days
- Butalbital: True positive, found in combination headache medications
- Pentobarbital: True positive, detectable roughly 3 days
- Secobarbital: True positive, detectable roughly 3 days
- Amobarbital: True positive, detectable roughly 3 days
- Primidone: True positive, metabolizes into phenobarbital
- Ibuprofen: Occasional false positive on initial screen
- Naproxen: Occasional false positive on initial screen
- Phenytoin: Documented false positive on initial screen
If you’re taking any prescription from this list for a legitimate medical condition, having your prescription records available can help clarify a positive result. For the over-the-counter painkillers, confirmatory testing is the straightforward path to clearing a false positive.